People are 'scratching and clawing' for negative narrative around obesity drugs: Mizuho's Jared Holz
Jared Holz, a healthcare sector specialist for Mizuho, joins 'Fast Money' to discuss Eli Lilly earnings, the demand for obesity drugs, and more.
Jared Holz, Mizuho Healthcare sector specialist, is on 'Fast Money to discuss Eli Lilly earnings. He talks about the demand for drugs to treat obesity and other topics.